CAPSA has been acquired by Acrotec SA
The private owners of CAPSA – Camille Piquerez SA (CAPSA) have sold the company to Acrotec SA, a portfolio company of Carlyle Group.
CAPSA is the leading manufacturer of small parts for the Swiss watch industry. Located in the center of the Swiss watchmaking region, the company produces high-precision and high-quality components for watch casing and watch movement. It operates a state-of-the-art machinery park with more than 375 machines. CAPSA was a family-owned company, and its roots go as far back as 1935, when it was founded as a manufacturer of bicycles. It ventured into producing watch-making components in 1951. As a member of the Responsible Jewelry Council (RJC) since 2015, the company adopts ethical, environmental, human rights and social welfare practices throughout its supply chain.
Through its companies, the Acrotec Group brings together unique and complementary skills in the high-precision technology markets. Be it with high-tech components or with specialized services, the Acrotec Group is present in the watchmaking, medtech, automotive, aerospace, aeronautics and electronics industries. The group’s companies are located mainly in Switzerland, France and the US.
Oaklins’ team in Switzerland acted as the exclusive sell-side advisor to the shareholders of CAPSA in the transaction.
Daniel Streit
Chairman of the Board of Directors, CAPSA - Camille Piquerez SA
Contáctese con el equipo de la transacción
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más